Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sensors spot MS walking issues early

NCT ID NCT06634225

Diagnosis Sponsor: Lille Catholic University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether special wearable sensors can detect early walking and balance problems in people with multiple sclerosis (MS). Researchers compared 70 participants (MS patients and healthy volunteers) as they walked on a platform with sensors. The goal was to see if these sensors could reliably measure movement, potentially helping doctors spot issues sooner and track rehabilitation progress.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Trigno® Avanti Sensor inertial units
What this could lead to
If validated, these sensors could become a simple tool to detect early balance and walking issues in MS, helping guide rehabilitation.
What could go wrong
This is a small, completed study focused on validating the sensor's accuracy, not on treatment. The results may not lead to widespread clinical use without further testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

70 people

The number who actually took part.

Started

Nov 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Multiple sclerosis patients and volunteers

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for patient: * Age 18 to 65 (inclusive) * Expanded Disability Status Scale (EDSS) ≤ 4 * Proficient in French * Agreeing to participate in the study and having signed the informed consent form * Affiliated with a social security scheme Inclusion Criteria for Volunteers: * Age 18 to 65 (inclusive) * Proficient in French * Agreeing to participate in the study and having signed the informed consent form * Affiliated with a social security plan Exclusion Criteria for patient: * MS crisis within the last 6 weeks * Botulinum toxin injection in the last 3 months * Neurological pathology other than MS * Disabling musculoskeletal pathology * Unstable cardiac and respiratory pathology * Pregnant women * Patients with comprehension or cognitive disorders * Recent change in background treatment (\< 3 months) * Patients under guardianship or curatorship * Presence of implanted electronic devices of any kind, including pacemakers or similar assistive devices, electronic infusion pumps and implanted pacemakers * Allergy to silver Exclusion Criteria for Volunteers: * Neurological pathology * Rheumatological pathology * Antecedent of sprains (\< 3 months), fractures (\< 1 year) in the lower limbs * Pregnant women * Person under guardianship or trusteeship * Presence of implanted electronic devices of any kind, including pacemakers or similar assistive devices electronic infusion pumps and implanted pacemakers * Allergy to silver

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coordination and balance disturbances are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coordination and balance disturbances Medical device Multiple sclerosis

Contacts and locations

Locations

  • Saint-Amand-Les-Eaux Hospital

    Saint-Amand-les-Eaux, Hauts-de-France, 59230, France

  • Saint-Philibert Hospital

    Lomme, Hauts-de-France, 59462, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.